Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis

被引:6
作者
Zhao, Jiefeng [1 ]
Zhu, Jinfeng [1 ]
Huang, Chao [1 ]
Zhu, Xiaojian [2 ]
Zhu, Zhengming [1 ]
Wu, Qinrong [3 ]
Yuan, Rongfa [1 ]
机构
[1] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 7, Ctr Digest Dis, Shenzhen, Peoples R China
[3] Yingtan City Peoples Hosp, Dept Gen Surg, Yingtan, Jiangxi, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
immunology journal; B-ibliometric analysis; CiteSpace; R-bibliometrix; the coronavirus disease 2019 (COVID-19); CORONAVIRUS DISEASE 2019; MONOCLONAL-ANTIBODY; CYTOKINE STORM; OPEN-LABEL; SARS-COV-2; VACCINE; VARIANT; SAFETY; NEUTRALIZATION; INTENTION;
D O I
10.3389/fimmu.2022.1035151
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundSince the global epidemic of the coronavirus disease 2019 (COVID-19), a large number of immunological studies related to COVID-19 have been published in various immunology journals. However, the results from these studies were discrete, and no study summarized the important immunological information about COVID-19 released by these immunology journals. This study aimed to comprehensively summarize the knowledge structure and research hotspots of COVID-19 published in major immunology journals through bibliometrics. MethodsPublications on COVID-19 in major immunology journals were obtained from the Web of Science Core Collection. CiteSpace, VOSviewer, and R-bibliometrix were comprehensively used for bibliometric and visual analysis. Results1,331 and 5,000 publications of 10 journals with high impact factors and 10 journals with the most papers were included, respectively. The USA, China, England, and Italy made the most significant contributions to these papers. University College London, National Institute of Allergy and Infectious Diseases, Harvard Medical School, University California San Diego, and University of Pennsylvania played a central role in international cooperation in the immunology research field of COVID-19. Yuen Kwok Yung was the most important author in terms of the number of publications and citations, and the H-index. CLINICAL INFECTIOUS DISEASES and FRONTIERS IN IMMUNOLOGY were the most essential immunology journals. These immunology journals mostly focused on the following topics: "Delta/Omicron variants", "cytokine storm", "neutralization/neutralizing antibody", "T cell", "BNT162b2", "mRNA vaccine", "vaccine effectiveness/safety", and "long COVID". ConclusionThis study systematically uncovered a holistic picture of the current research on COVID-19 published in major immunology journals from the perspective of bibliometrics, which will provide a reference for future research in this field.
引用
收藏
页数:29
相关论文
共 196 条
[91]   Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19 [J].
Manayi, Azadeh ;
Nabavi, Seyed Mohammad ;
Khayatkashani, Maryam ;
Habtemariam, Solomon ;
Khayat Kashani, Hamid Reza .
MOLECULAR BIOLOGY REPORTS, 2021, 48 (12) :8221-8225
[92]   'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 [J].
Mandal, Swapna ;
Barnett, Joseph ;
Brill, Simon E. ;
Brown, Jeremy S. ;
Denneny, Emma K. ;
Hare, Samanjit S. ;
Heightman, Melissa ;
Hillman, Toby E. ;
Jacob, Joseph ;
Jarvis, Hannah C. ;
Lipman, Marc C., I ;
Naidu, Sindhu B. ;
Nair, Arjun ;
Porter, Joanna C. ;
Tomlinson, Gillian S. ;
Hurst, John R. .
THORAX, 2021, 76 (04) :396-398
[93]   Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster [J].
Marcotte, Harold ;
Hammarstrom, Lennart ;
Pan-Hammarstrom, Qiang .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
[94]  
Martinez DR, 2021, SCIENCE, V373, P991, DOI [10.1126/science.abi4506, 10.1101/2021.03.11.434872]
[95]   The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 [J].
Mastaglio, Sara ;
Ruggeri, Annalisa ;
Risitano, Antonio M. ;
Angelillo, Piera ;
Yancopoulou, Despina ;
Mastellos, Dimitrios C. ;
Huber-Lang, Markus ;
Piemontese, Simona ;
Assanelli, Andrea ;
Garlanda, Cecilia ;
Lambris, John D. ;
Ciceri, Fabio .
CLINICAL IMMUNOLOGY, 2020, 215
[96]   Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy [J].
Mastellos, Dimitrios C. ;
Pires da Silva, Bruno G. P. ;
Fonseca, Benedito A. L. ;
Fonseca, Natasha P. ;
Auxiliadora-Martins, Maria ;
Mastaglio, Sara ;
Ruggeri, Annalisa ;
Sironi, Marina ;
Radermacher, Peter ;
Chrysanthopoulou, Akrivi ;
Skendros, Panagiotis ;
Ritis, Konstantinos ;
Manfra, Ilenia ;
Iacobelli, Simona ;
Huber-Lang, Markus ;
Nilsson, Bo ;
Yancopoulou, Despina ;
Connolly, E. Sander ;
Garlanda, Cecilia ;
Ciceri, Fabio ;
Risitano, Antonio M. ;
Calado, Rodrigo T. ;
Lambris, John D. .
CLINICAL IMMUNOLOGY, 2020, 220
[97]   Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications [J].
Mathew, Divij ;
Giles, Josephine R. ;
Baxter, Amy E. ;
Oldridge, Derek A. ;
Greenplate, Allison R. ;
Wu, Jennifer E. ;
Alanio, Cecile ;
Kuri-Cervantes, Leticia ;
Pampena, M. Betina ;
D'Andrea, Kurt ;
Manne, Sasikanth ;
Chen, Zeyu ;
Huang, Yinghui Jane ;
Reilly, John P. ;
Weisman, Ariel R. ;
Ittner, Caroline A. G. ;
Kuthuru, Oliva ;
Dougherty, Jeanette ;
Nzingha, Kito ;
Han, Nicholas ;
Kim, Justin ;
Pattekar, Ajinkya ;
Goodwin, Eileen C. ;
Anderson, Elizabeth M. ;
Weirick, Madison E. ;
Gouma, Sigrid ;
Arevalo, Claudia P. ;
Bolton, Marcus J. ;
Chen, Fang ;
Lacey, Simon F. ;
Ramage, Holly ;
Cherry, Sara ;
Hensley, Scott E. ;
Apostolidis, Sokratis A. ;
Huang, Alexander C. ;
Vella, Laura A. ;
Betts, Michael R. ;
Meyer, Nuala J. ;
Wherry, E. John .
SCIENCE, 2020, 369 (6508) :1209-+
[98]   Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019 [J].
McEneny-King, Alanna C. ;
Monteleone, Jonathan P. R. ;
Kazani, Shamsah D. ;
Ortiz, Stephan R. .
INFECTIOUS DISEASES AND THERAPY, 2021, 10 (02) :1045-1054
[99]   Correlates of protection against SARS-CoV-2 in rhesus macaques [J].
McMahan, Katherine ;
Yu, Jingyou ;
Mercado, Noe B. ;
Loos, Carolin ;
Tostanoski, Lisa H. ;
Chandrashekar, Abishek ;
Liu, Jinyan ;
Peter, Lauren ;
Atyeo, Caroline ;
Zhu, Alex ;
Bondzie, Esther A. ;
Dagotto, Gabriel ;
Gebre, Makda S. ;
Jacob-Dolan, Catherine ;
Li, Zhenfeng ;
Nampanya, Felix ;
Patel, Shivani ;
Pessaint, Laurent ;
Van Ry, Alex ;
Blade, Kelvin ;
Yalley-Ogunro, Jake ;
Cabus, Mehtap ;
Brown, Renita ;
Cook, Anthony ;
Teow, Elyse ;
Andersen, Hanne ;
Lewis, Mark G. ;
Lauffenburger, Douglas A. ;
Alter, Galit ;
Barouch, Dan H. .
NATURE, 2021, 590 (7847) :630-634
[100]   Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents [J].
Mei, Jie ;
Zhou, Yatong ;
Yang, Xinping ;
Zhang, Fan ;
Liu, Xiufeng ;
Yu, Boyang .
JOURNAL OF ETHNOPHARMACOLOGY, 2021, 278